Clin Endosc.  2022 Mar;55(2):287-291. 10.5946/ce.2020.272.

Acute Liver Failure Secondary to Hepatic Infiltration of Malignant Melanoma

Affiliations
  • 1Department of Internal Medicine, Daegu Fatima Hospital, Daegu, Korea

Abstract

Acute liver failure due to malignant melanoma is uncommon. We presents a case of acute liver failure secondary to hepatic infiltration of a malignant melanoma. An 86-year-old man was admitted with elevated liver enzymes and an increased lactate dehydrogenase level. His condition progressed to acute liver failure, but the etiology of liver failure was unclear. Esophagogastroduodenoscopy was performed to evaluate dyspepsia, which showed signs indicative of malignant melanoma. Based on the endoscopy findings and elevated liver enzyme levels, liver biopsy was performed to confirm the presence of malignant melanoma. Hepatic infiltration of malignant melanoma was observed histologically. However, massive and diffuse liver metastasis is very rare and difficult to identify on imaging studies. If the etiology of liver failure is unclear, diffuse metastatic melanoma infiltration should be considered as differential diagnosis. Early liver biopsy can help to clarify the diagnosis.

Keyword

Acute liver failure; Hepatic infiltration; Liver biopsy; Malignant melanoma

Figure

  • Fig. 1. Computed tomography scan shows mild fatty change and small amount of ascites without focal lesions in the liver.

  • Fig. 2. Endoscopic findings. (A), (B) Multiple black pigmented spots and nodules are seen on the entire stomach. (C) A round deep ulcer with black pigmented base is seen at the lesser curvature of the antrum. (D) Multiple shallow ulcers with black pigmented base are seen in the duodenum.

  • Fig. 3. Magnetic resonance imaging shows multiple high signal intensity nodules without defined focal mass-like lesions in the liver on T2 blade.

  • Fig. 4. Stomach biopsy findings. (A) Stomach biopsy findings show nucleoli with distinct large nucleus and infiltrating tumor cells with brown pigmentation (hematoxylin & eosin stain, ×200). (B, C, D) Immunohistochemically, the tumor cells are positive for S-100, HMB45, and melan-A (immuhohistochemical stain, ×100).

  • Fig. 5. (A, B) Liver biopsy results show nucleoli with distinct large nucleus and infiltrating tumor cells with brown pigmentation (hematoxylin & eosin stain, ×100 and ×200).

  • Fig. 6. (A) The right second toenail color changed to black beyond the nail fold. (B) A brown spot with an irregular border and shape was found on the lower leg.


Reference

1. Curti BD, Leachman S, Urba WJ. Cancer of the Skin. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, eds. Harrison’s principles of internal medicine 20th ed. New York (NY): McGraw-Hill Education; 2018. p. 522-530.
2. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998; 83:1664–1678.
3. Dasgupta T, Bowden L, Berg JW. Malignant melanoma of unknown primary origin. Surg Gynecol Obste. 1963; 117:341–345.
4. Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 2001; 136:950–955.
5. Te HS, Schiano TD, Kahaleh M, et al. Fulminant hepatic failure secondary to malignant melanoma: case report and review of the literature. Am J Gastroenterol. 1999; 94:262–266.
6. Montero JL, Muntané J, de las Heras S, Ortega R, Fraga E, De la Mata M. Acute liver failure caused by diffuse hepatic melanoma infiltration. J Hepatol. 2002; 37:540–541.
7. Schlevogt B, Rehkämper J, Hild B, Schmidt HH. Hepatobiliary and pancreatic: fulminant liver failure from diffuse leukemoid hepatic infiltration of melanoma. J Gastroenterol Hepatol. 2017; 32:1795.
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr